Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $379,848 - $551,656
-2,800 Closed
0 $0
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $2.95 Million - $4.85 Million
-25,000 Reduced 89.93%
2,800 $331,000
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $4.22 Million - $6.36 Million
-36,000 Reduced 56.43%
27,800 $3.97 Million
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $4.55 Million - $8.46 Million
36,000 Added 129.5%
63,800 $11 Million
Q4 2021

Feb 15, 2022

BUY
$225.82 - $368.51 $5.8 Million - $9.47 Million
25,700 Added 1223.81%
27,800 $7.06 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $17.3 Million - $37.7 Million
-77,900 Reduced 97.38%
2,100 $808,000
Q2 2021

Aug 16, 2021

SELL
$129.91 - $234.98 $3.25 Million - $5.87 Million
-25,000 Reduced 23.81%
80,000 $18.8 Million
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $15.3 Million - $26 Million
-140,000 Reduced 57.14%
105,000 $13.8 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $5.42 Million - $14 Million
82,500 Added 50.77%
245,000 $25.6 Million
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $7.62 Million - $13.3 Million
140,300 Added 631.98%
162,500 $11.5 Million
Q2 2020

Aug 14, 2020

SELL
$29.67 - $80.0 $2.9 Million - $7.82 Million
-97,800 Reduced 81.5%
22,200 $1.43 Million
Q1 2020

May 12, 2020

BUY
$17.78 - $31.58 $2.13 Million - $3.79 Million
120,000 New
120,000 $3.59 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.